Trials / Completed
CompletedNCT04280367
Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age
Childhood Learning and Executive Function Disorders and Risk of Psychosis in the Adulthood
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 15 Years – 30 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study aims to study transition toward schizophrenia in patients with learning disorders, and to compare the risk between patients with specific learning disorders, and patients with complexed learning disorders (by two types: patients with other neuro-developmental disorders including executive function disorders, and patients with anxiety).
Detailed description
As secondary objectives, the study aims to: * argue the clinical predicted markers (neuropsychological) transition toward psychosis. * test the feasibility and the acceptability of a early diagnosis for a potential applicable guidance for different referent centers of learning in French territory. * have a better classification of patients with learning disorders in order to target a prospective primary prevention of risk of psychosis via the questionnaires (AQ of Baron-Cohen: Autism-spectrum quotient auto-questionnaire; Inventory of Beck Anxiety Inventory, auto-questionnaire for panic disorder and general anxiety; Liebowitz Social Anxiety Scale). * improve identification of the early signs and the early emerging psychological diseases intervention management (schizophrenia). * Psychic disability: prevent and reduce non-seeking care and accompaniment situations, and risk of rupture of care. * permitting better care of psychosocial rehabilitation with cognitive evaluation. This study will be conducted in Centre de référence des troubles du langage et des apprentissages, Hôpital Raymond Poincaré, APHP, in France.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Standardised semi-structured talk | Comprehensive assessment of at-risk mental states (CAARMS) will be used. |
| DIAGNOSTIC_TEST | Autistic spectre disorder screening | Autism-spectrum quotient (AQ) auto-questionnaire will be used. |
| DIAGNOSTIC_TEST | Anxiety measuring | An inventory for measuring clinical anxiety: Beck Anxiety Inventory (BAI); Liebowitz Social Anxiety Scale. |
Timeline
- Start date
- 2020-01-28
- Primary completion
- 2020-05-29
- Completion
- 2020-05-29
- First posted
- 2020-02-21
- Last updated
- 2023-08-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04280367. Inclusion in this directory is not an endorsement.